Senior insider sale
Chief Technology Officer at KYVERNA THERAPEUTICS, INC. — senior position signals high conviction
$118.2K
12.46K shares
What this filing means
WALKER KAREN MARIE plans to sell 12.46K shares of KYVERNA THERAPEUTICS, INC. valued at approximately $118.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/17/2026ACC: 0001950047-26-003607
Officer· Chief Technology Officer
Since Feb 2024
12.46K
Shares to sell
$118.2K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/17/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/17/2026 | Exercise of Stock Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.46K
Market value
$22.9K
4/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$95.3K
4/17/2026
Total
Units
12.46K
Value
$118.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 2.46K | $22.9K | — | Completed |
| Planned — Approximate Date | ||||
4/17/2026 | 10K | $95.3K | NASDAQ | Planned |
| Total | 12.46K | $118.2K | ||